INFINITY PHARMACEUTICALS INC (INFI)       0.4999  +0.01 (+2.02%)

0.4999  +0.01 (+2.02%)

US45665G3039 - Common Stock

Buy % Consensus

Analysts have set a mean price target of 4.46. This target is 792.68% above the current price.
INFI was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INFI.
In the previous month the buy percentage consensus was at a similar level.
INFI was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 0.501.523.574.469.45 - 203.06% 614.14% 792.68% 1,790.38%

Up and Down Grades

Date Firm Action Rating
2022-11-16 B. Riley Securities Downgrade Buy -> Neutral
2022-05-23 Piper Sandler Maintains Overweight
2021-10-18 HC Wainwright & Co. Initiate Buy
2021-08-02 JP Morgan Upgrade Neutral -> Overweight
2021-07-28 Wells Fargo Upgrade Equal-Weight -> Overweight
2021-03-18 Truist Securities Initiate Buy
2021-03-17 Wells Fargo Maintains Equal-Weight
2021-02-18 Piper Sandler Initiate Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA